Neurology
The most recent articles from:
Neurology
-
To investigate the impact of the adjustment of initial intracerebral hemorrhage (ICH) volume by onset-to-imaging time (ultraearly hematoma growth [uHG]) on further hematoma enlargement and outcome in patients with acute ICH. ⋯ The uHG represents a powerful and easy-to-use tool for improving the prediction of HG and outcome in patients with acute ICH.
-
Randomized Controlled Trial Multicenter Study
OnabotulinumtoxinA improves quality of life and reduces impact of chronic migraine.
To assess the effects of treatment with onabotulinumtoxinA (Botox, Allergan, Inc., Irvine, CA) on health-related quality of life (HRQoL) and headache impact in adults with chronic migraine (CM). ⋯ This study provides Class 1A evidence that onabotulinumtoxinA treatment reduces headache impact and improves HRQoL.
-
Editorial Comment
Where's the fire? Long-term neurologic outcome following cardiac arrest.